-
2025-520660-18-00
6
2026-05-08
Heart Failure
-
2025-523742-27-00
9
2026-04-28
Advanced solid tumors
-
2025-520902-37-00
4
2026-04-01
Non-small cell lung cancer stage IV
-
2025-521314-25-00
5
2026-03-19
NPM1-m and KMT2A-r Acute Myeloid Leukemia
-
2025-520675-86-00
4
2026-03-10
Unresectable or Metastatic Hepatocellular Carcinoma and Compensated Li
-
2025-521919-39-00
3
2026-02-10
Resected stage IIB, IIC, or III melanoma requiring adjuvant treatment
-
2025-522767-15-00
5
2026-01-27
Acute Myeloid Leukemia
-
2025-521299-76-00
7
2025-12-18
Relapsed or refractory acute leukaemia or Myelodysplastic Syndromes wi
-
2025-522669-32-00
5
2025-12-18
Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lym
-
2024-519479-24-00
4
2025-11-21
metastatic colorectal cancer
-
2025-521775-31-00
5
2025-11-12
Stage IB-IIIA NSCLC Patients with uncommon EGFR Mutations
-
2025-521088-10-00
4
2025-10-23
Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) or Small
-
2024-516646-19-00
5
2025-08-15
Type 2 diabetic patients with no prior cardiovascular (CV) events
-
2024-516792-32-01
4
2025-07-18
Metastatic non-squamous non-small cell lung cancer
-
2024-518359-47-00
10
2025-06-17
Acute Myeloid Leukemia
-
2023-504478-39-00
5
2025-05-23
Squamous cell carcinoma of head and neck
-
2024-515459-39-00
7
2025-05-08
Advanced or Metastatic Squamous Solid Tumors
-
2024-514517-35-00
5
2025-02-27
Acute myeloid leukemia
-
2024-515451-38-00
5
2025-02-27
Primary Immune thrombocytopenia (ITP)
-
2024-516874-31-00
5
2024-12-10
Patients with a low-grade serous epithelial carcinoma of the ovary (LG
-
2022-501105-12-00
5
2024-07-15
Urothelial Carcinoma
-
2023-505486-92-00
4
2024-02-09
Small bowel adenocarcinoma
-
2022-502660-20-00
5
2024-01-23
Follicular lymphoma
-
2022-501427-24-00
4
2023-04-25
Nonadvanced Systemic Mastocytosis